Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

Ozempic, Wegovy have become the pharmaceutical drugs of the moment thanks to their powerful weight loss effects.

Nearly half of Americans have said they would take one of these so-called GLP-1 agonists, which are part of a market projected to be worth as much as $100 billion by 2030.